News
Spirair, Inc., an early-stage company developing minimally invasive solutions to help ENTs improve patient care, today ...
SEATTLE -- Weight loss drugs have gained momentum as treatment for obstructive sleep apnea (OSA) at sleep clinics across the ...
Australia's Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnea, a condition in which breathing stops and starts repeatedly during sleep.
Last week, Australia ’s Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnoea, ...
SEATTLE -- Psychological evaluation before implantation of a hypoglossal nerve stimulation (HNS) device to treat obstructive ...
According to a new study, presented at the American College of Cardiology (ACC) Care of the Athletic Heart 2025 conference, ...
Australia's Therapeutic Goods Administration (TGA) approved the weight-loss drug Mounjaro to treat sleep apnoea, a condition in which ...
Capital structure streamlined and potential dilution from Series A Warrants eliminated ahead of key Phase 2 clinical milestonesNEW YORK and MELBOURNE, Australia, June 12, 2025 (GLOBE NEWSWIRE) -- ...
Some groups are at higher risk for complications, including children and people with underlying health conditions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results